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EVIDENCE B R I E F
  Family planning is most successful 
when clients have a variety of 
methods to choose from and a variety 
of service delivery sites from which to 
obtain them. (1)
The private sector plays a critical role in family planning (FP) 
and can contribute to a total market approach to providing 
contraceptives (2). The private sector accounts for around 
two-fifths of contraceptive provision worldwide (3), with the 
share higher in some countries; in Nigeria 60% of women obtain 
contraception in the private sector (4). The private sector ranges 
from nongovernmental and faith-based organizations, usually 
providing free or subsidized services, to for-profit medical 
providers, pharmacies and drug shops. Workplaces also offer a 
private sector venue for providing health services, including FP. 
As countries move towards their FP2020 goals and increase 
domestic resources to do so, the private sector is a critical 
partner (5). Among private sector service options, social 
marketing, social franchising, and pharmacies and drug shops 
most readily contribute to sustainable markets for contraceptive 
services. Corporate sector workplace programmes also show 
promise for reaching millions of women.  
SOCIAL MARKETING 
Social marketing uses marketing techniques to achieve 
behavioural change coupled with making contraceptives 
available through private sector outlets. It has been successful in 
promoting a wide range of contraceptive methods, with strong 
evidence showing its impact on the availability of injectables in 
Bangladesh, condoms in Pakistan, and Cyclebeads to support 
the Standard Days Method in Benin, the Democratic Republic 
of the Congo and Ecuador (6). Between 1990 and 2010, social 
marketing programmes doubled the number of couple-years of 
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POLICY AND PROGRAM 
CONSIDERATIONS
 As part of a total market approach, 
governments should ensure that 
regulations support private sector 
provision of contraceptives and that 
the private sector complies with public 
sector health standards. 
 Attention to equity, quality, affordability, 
access, method choice, and good 
counselling is important to ensure 
that women obtaining information and 
contraceptives from private sector 
sources are making full, free and 
informed decisions.
 Governments could include the private 
sector in funding proposals to the Global 
Financing Facility, which leverages 
private sector capabilities in delivery and 
supply chains to improve access to family 
planning. 
 Governments should engage industry 
in developing policies and programmes 
that expand access to family planning 
information, products and services in the 
workplace.
 Governments should explore schemes at 
scale for contracting, reimbursement and 
subsidising social marketing and social 
franchising networks to promote quality 
services and equitable, affordable access 
to comprehensive SRH.
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protection that they support (7). In Nigeria, sales of long-
acting and reversible contraceptives (LARCs) in one social 
marketing programme in 2015 exceeded 100,000 (8).
Social marketing taps into large networks of private 
providers, helps reduce geographic and socioeconomic 
disparities by reaching women who are young, poor and 
living in rural areas (9), and reaches men and boys, who are 
typically not well-served by health facilities (10).
 
SOCIAL FRANCHISING 
Social franchising (11) is the provision of contraceptives 
in “branded” private facilities designed to expand the 
market for contraceptives with high-quality, cost-effective 
and equitable services that reach a range of population 
groups (12). Social franchising has produced increases 
in the provision of LARCs as those methods become 
more widely available in a number of countries, including 
Kenya and Nigeria (13). Social franchising attracts hard-
to-reach groups, including young women and low-income 
clients, and also successfully reaches new clients (14). 
Social franchised private facilities that offer prenatal and 
childbirth services can also increase use of postpartum 
family planning (15).
DRUG SHOPS AND PHARMACIES 
Drug shops and pharmacies are important sources of health 
care, particularly in rural areas or urban slums with few 
public clinics (16). They are often the first stop for women 
and men who seek FP information or services. These two 
sources account for most of the private sector provision 
of contraception in sub-Saharan Africa, especially for 
condoms, pills, injectables and emergency contraception 
(17). 
Women in Tanzania who obtain oral contraceptives 
from pharmacies are able to self-screen their eligibility 
for contraceptive use as accurately as nurses (18), and 
in Bangladesh, trained drug shop staff can safely and 
effectively provide injectables and other methods (19). 
Recent evidence from Nigeria shows that patent medical 
vendors can provide injectables safely, and so could 
significantly expand access to contraception in countries 
where such sources are widely available (20). Pharmacy 
supply of low-cost emergency contraception in South 
Africa and in many low-income countries increases access 
to that method (21). Pharmacies and drug shops are also 
convenient for adolescents, as well as for men and boys, 
both as sources of information and for the supply of 
products for themselves and their partners. 
WORKPLACE POLICIES  
AND PROGRAMMES 
Expanding access to family planning information, products 
and services requires a more expansive approach to how 
the global health community engages with the corporate 
sector. Multinational and national corporations and their 
supplier companies employ millions of women, men and 
young people, many of whom have left rural homes to 
take jobs in towns and cities. Employed urban workers 
have significant reproductive health (RH) needs, and 
workplace clinics could be the first points of contact for 
FP information, counselling and referrals. Setting global 
standards that encourage corporations to ensure that 
companies and factories from which they obtain products 
provide access to health care, including FP/RH, would help 
reach millions of women. 
Research in Cambodia found that RH and FP were the main 
health needs of workers, who face many barriers to services 
that businesses and the government can help overcome 
(22). As more people move to urban areas and industries 
develop in emerging economies, the workplace can be 
an important venue for changing norms, developing new 
networks of contraceptive users and expanding access to 
services. For example, the Family Guidance Association 
of Ethiopia, which works with more than 150 enterprises 
to improve health services and referrals, analysed health 
outcomes in one client factory over 10 years and found 
reductions in unintended pregnancies and STIs as well as 
sick leave. Uptake of contraception rose from 11% to 90% 
between 1997 and 2000 (23). 
In 2016, a tripartite agreement between the Bangladesh 
Directorate General for Family Planning, the Bangladesh 
Garment Manufacturers Export Association and 
EngenderHealth Bangladesh enables BGMEA to provide 
training and free contraceptives to factory clinics, with the 
potential to reach thousands of factory workers (24). 
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and programme considerations for improving access to family 
planning and reducing unintended pregnancy. Programme 
considerations are based on the expert views of the authors, 
who undertook desk reviews drawing on existing evidence.
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